Feed NVO
NV
Novo Nordisk
NVO · NYSE
$48.19 -2.42% (-$1.20)
1M +9.63%
Market Cap 1.4T kr
P/E Ratio 13.85x
Div. Yield 3.65%
ROE 66.95%
Bulios Fair Price
$112.09
132.6% upside
Aktuální cena
$48.19
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
37 /100
Fair P/E 13.85x
EV/EBITDA 9.20x
PEG 9.80x
Growth
75 /100
Growing EPS growth 23.52%
Rev. growth 20.43%
Book val. growth 32.46%
Profitability
100 /100
Strong Gross margin 82.05%
Net margin 32.88%
FCF margin 19.88%
Quality
92 /100
Excellent ROIC 35.99%
ROE 66.95%
Asset turnover 0.62x
Debt
63 /100
Moderate Debt/Equity 0.60x
Current ratio 0.78x
Net debt/EBITDA 0.42x
Stability
46 /100
Moderate Beta 0.36x
Rev. volatility 12.92%
Profitable years 6
Zeptejte se StockBota na NVO
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Maziar Mike Doustdar
Employees
77,406
Headquarters
Bagsvaerd
Nadcházející události
05 SRP
Earnings
Upcoming earnings report